Loading
Anthony Gonçalves is a medical oncologist leading breast and ovarian cancer research at Institut Paoli-Calmettes.
Anthony Gonçalves is Head of Medical Oncology at Institut Paoli-Calmettes in Marseille, part of the UNICANCER network of French cancer centres. His specialisms are breast cancer, ovarian cancer and translational research, and he leads UNICANCER breast and gynaecological trials alongside translational genomics programmes. His papers include the UCBG 12-1 phase II trial of abiraterone acetate plus prednisone in androgen receptor-positive triple-negative breast cancer, the New England Journal of Medicine report of talazoparib in advanced breast cancer with a germline BRCA mutation, and the BAYPAN phase III trial of gemcitabine with sorafenib in advanced pancreatic cancer. His publications are listed on PubMed.
Shares UNICANCER, HR-positive / HER2-negative breast cancer.
Shares UNICANCER, Ovarian cancer, HR-positive / HER2-negative breast cancer.
Shares UNICANCER, HR-positive / HER2-negative breast cancer.
Shares UNICANCER, Ovarian cancer.
Shares UNICANCER, HR-positive / HER2-negative breast cancer.
Shares UNICANCER, Ovarian cancer.